Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.NPS Pharmaceuticals, a developer of specialty therapeutics for gastrointestinal and endocrine disorders, has appointed Roger Garceau as its new senior vice president of R&D and chief medical officer, effective December 11, 2008.
Subscribe to our email newsletter
Dr Garceau replaces Alan Harris who is leaving NPS for personal reasons but remains as a scientific advisor to the company.
Dr Garceau joins NPS from Sanofi-Aventis, where he served in a number of senior leadership positions and brings over 20 years of broad pharmaceutical industry experience to his position.
Dr Garceau has received a bachelor of science in biology from Fairfield University in Fairfield, Connecticut and his doctorate of medicine from the University of Massachusetts Medical School.
Francois Nader, president and CEO of NPS, said: “Roger brings great experience in clinical development, medical affairs and new product marketing that will be invaluable as we advance our late-stage development programs, Gattex and NPSP558.”